The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
about
The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes MellitusBugging inflammation: role of the gut microbiotaPart 2: Treatments for Chronic Gastrointestinal Disease and Gut DysbiosisHuman microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approachesIncreased Intake of Foods with High Nutrient Density Can Help to Break the Intergenerational Cycle of Malnutrition and ObesityGut microbes and host physiology: what happens when you host billions of guests?Gut microbiota and gastrointestinal health: current concepts and future directionsDo interactions between gut ecology and environmental chemicals contribute to obesity and diabetes?Human gut microbiota: repertoire and variationsTherapeutic options in pediatric non alcoholic fatty liver disease: current status and future directionsAn analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesisA discrete genetic locus confers xyloglucan metabolism in select human gut BacteroidetesIs eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanismsPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters.Pediatric non-alcoholic fatty liver disease: New insights and future directionsCan psychobiotics intake modulate psychological profile and body composition of women affected by normal weight obese syndrome and obesity? A double blind randomized clinical trialThe changing hypothesis of the gut. The intestinal microbiome is increasingly seen as vital to human health.Lactobacillus species causing obesity in humans: where is the evidence?The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial.Worms need microbes too: microbiota, health and aging in Caenorhabditis elegansGastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM.The nonfermentable dietary fiber hydroxypropyl methylcellulose modulates intestinal microbiota.The devil lies in the details: how variations in polysaccharide fine-structure impact the physiology and evolution of gut microbes.Fecal microbiota transplantation broadening its application beyond intestinal disorders.Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: A meta-analysis of randomized, controlled trialsFunctional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity.The pathophysiology of hypertension in patients with obesity.The gut microbiome as novel cardio-metabolic target: the time has come!Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet.Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals.Understanding the role of gut microbiome in metabolic disease risk.Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters.Administration of defined microbiota is protective in a murine Salmonella infection model.Calcium supplementation modulates gut microbiota in a prebiotic manner in dietary obese mice.Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials.Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes.The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology.
P2860
Q26745148-8CC332A5-83D7-4414-BB82-66C2D320DD06Q26748440-0DAB95F1-BDF0-496A-9FDA-B495F72D9110Q26771942-D96A7F1A-B9BB-4F56-80B7-EFAF5CA8218AQ26779242-2FE78131-B934-496D-B734-54A84F9C8C25Q26801379-9E0737D4-0990-4FFD-821F-C348FB40DFBAQ26822836-7A1A96EA-1C1A-41E0-ADEC-AC5E8BE971F8Q26865880-838D5E42-A88D-48F5-801C-ACB512143EEAQ27010006-97D8C8BD-24CD-4568-87A6-AA209CC4AD78Q27020975-CF62B1A5-65EC-48F3-B5BB-A19AEB362EC4Q27028844-F4056F88-A482-4147-BEA6-B54FE79E4989Q27310177-D4E71E98-BDD8-4D35-A357-9F8F2BF2D70FQ27681458-9BE413A8-1183-47B2-BCA4-F2A297F40B19Q28245530-E67F5F57-7CF6-4066-9054-3E649A2483A7Q30597265-7B66947E-38CE-4253-A56E-A7DA2CC92290Q31101955-88FDC4DC-3BC1-404A-902A-191C2639CC77Q33563887-CDC2B13D-1912-4F7C-B37A-D7EB328112DEQ33785098-0E100412-D68E-498B-AFF1-A5AC2DEC7A4CQ34268562-844B3972-7F32-464B-9F0F-868551E40CB8Q34299113-8B111B4B-3BB6-467A-B78C-A67E5BEA5713Q34311324-2E3A3731-08BB-48E8-95E5-4C1C58B2237EQ34361733-05C89C50-CF9B-4E17-A412-DC1F304E4204Q34366918-9E70AAFA-7F98-4D56-A9B1-102F87A1A6E6Q34427074-7911304D-4FD0-4E16-95BF-91A3493AF720Q34478839-EDEBE3C8-39EA-4A73-BFD9-6C3BAA4F01BAQ34615974-9F3FA1A9-75F3-4890-AB66-9410006E3597Q34667433-FAD8877E-73A2-4E0F-B599-FDAA96E8BB77Q34677719-1FE2A59E-69ED-4EAB-8BE7-749D3635FE3BQ34778080-D15A8BFA-A28A-48AE-AAAB-CF727EF03C15Q35021492-231A3216-B9A5-4532-8737-54DC7A6B8CCFQ35038619-49F2DD20-8176-4B7F-BBA0-04681C242F5FQ35095134-200CB99C-0FCD-4670-9494-98BEB353B0F9Q35113086-DE139DC4-BD44-42FB-A237-AF3BDD08BAF9Q35331225-AAFE8E85-EF2D-43F5-B13E-5B66099AD327Q35544903-C0E9B2F3-13DF-486F-A1F8-84753FF77160Q35620634-779A6B18-7978-46B1-B0DF-ECF1E65F1817Q35831349-1CC84ACF-CF0C-40A9-A8F8-921D25731863Q35845777-DE023550-B95F-4C7A-BC07-CBD42AC7597AQ36122235-FB5D7A78-B97A-4F93-AFB8-054E8EB7E7A5Q36208733-F428AFD8-82C6-466D-B5AC-8D5D7D1809F1Q36275800-BEB7ADCD-AAEC-4F62-BFBE-C92D6D2A99EB
P2860
The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The therapeutic potential of m ...... and type 2 diabetes mellitus.
@en
The therapeutic potential of m ...... and type 2 diabetes mellitus.
@nl
type
label
The therapeutic potential of m ...... and type 2 diabetes mellitus.
@en
The therapeutic potential of m ...... and type 2 diabetes mellitus.
@nl
prefLabel
The therapeutic potential of m ...... and type 2 diabetes mellitus.
@en
The therapeutic potential of m ...... and type 2 diabetes mellitus.
@nl
P2093
P2860
P1476
The therapeutic potential of m ...... and type 2 diabetes mellitus.
@en
P2093
E G Zoetendal
E S Stroes
F Holleman
G M Dallinga-Thie
J B L Hoekstra
M Nieuwdorp
R S Kootte
W M de Vos
P2860
P304
P356
10.1111/J.1463-1326.2011.01483.X
P577
2011-11-22T00:00:00Z